| Ab-interno trabeculectomy with novel ablative device encouraging based on case series outcomes
| Direct comparison with standard trabeculectomy is needed, according to physician
| | Ophthalmology Times | Outcomes data for ab-interno trabeculectomy with a novel ablative device (Trabectome, NeoMedix) to ablate thermally the trabecular meshwork consist of case series. So far, this procedure has been associated with favorable IOP lowering, but a direct comparison with standard trabeculectomy is needed, according to one glaucoma specialist. |
| | Mini glaucoma shunt viable surgical alternative
| Compared with trabeculectomy, outcomes showed similar IOP-lowering efficiency
| | Ophthalmology Times | | Surgical outcomes were compared in a retrospective study of 76 eyes with a miniature glaucoma shunt (Ex-PRESS, Optonol) implanted and 77 eyes that underwent standard trabeculectomy. The two procedures were associated with similar IOP-lowering efficacy, but the shunt procedure had a benefit for reducing the risk of hypotony. |
| | Modification minimizes complications of trabeculectomy
| | Ophthalmology Times | | Implantation of a miniature glaucoma device (Ex-PRESS R-50, Optonol) under a scleral flap is a modification of trabeculectomy that appears to provide similar IOP-lowering efficacy but with fewer complications. |
| | Trabecular micro-bypass stent shows favorable safety and efficacy profile
| Ab-interno approach avoids conjunctival scarring and a filtering bleb, says physician
| | Ophthalmology Times | | A trabecular bypass micro stent (iStent, Glaukos) was developed to restore fully natural physiologic outflow in glaucomatous eyes by allowing flow of aqueous from the anterior chamber into Schlemm's canal. |
| |
| Important eye health issues examined in Ophthalmology journal
| | Ophthalmology Times | Three studies on eye health examine the role of antioxidant supplements, the relationship of visual acuity and mortality, and the causes of glaucoma in the May 2008 issue of Ophthalmology, the journal of the American Academy of Ophthalmology.
|
| | Risk of glaucoma increases with diabetes, study supports
| | Ophthalmology Times | | It appears that diabetic retinopathy is not the only eye disease associated with diabetes, according to a study, which found that women with diabetes have about a 70% increased risk of developing the most common form of glaucoma—primary-open angle glaucoma—compared with women without diabetes. |
| | Alcon's Cary Rayment honored as a 'catalyst' for glaucoma work
| Commitment to glaucoma research strong after 25 years in eye-care industry
| | Ophthalmology Times | | Cary Rayment, who was honored Jan. 23 by the Glaucoma Research Foundation (GRF) with the 2008 GRF Catalyst Award, is leading his company's strategic plan to spend more than $3.5 billion on research over the next 5 years. |
|
| 
